Bessemer Group Inc Agios Pharmaceuticals, Inc. Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 120 shares of AGIO stock, worth $3,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120Holding current value
$3,937% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AGIO
# of Institutions
240Shares Held
57.9MCall Options Held
407KPut Options Held
473K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$186 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$185 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$159 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$123 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$92.9 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.8B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...